The study on pro-adrenomedullin as a new biomarker in sepsis prognosis and risk stratification

Chinese Critical Care Medicine

Volumn 20, Issue 8, 2008, Pages 452-455

  Kang, Fu Xin ^a   Wang, Rui Lan ^a   Yu, Kang Long ^a   Wei, Qiao ^a  

^a SHANGHAI JIAO TONG UNIVERSITY   (China)

Author keywords

Pro adrenomedullin; Prognosis; Risk stratification; Sepsis

Indexed keywords

BIOLOGICAL MARKER; C REACTIVE PROTEIN; INTERLEUKIN 6; PROADRENOMEDULLIN; PROCALCITONIN;

ADULT; AGED; APACHE; AREA UNDER THE CURVE; ARTICLE; CONTROLLED STUDY; CRITICALLY ILL PATIENT; DISEASE MARKER; DISEASE SEVERITY; ENZYME IMMUNOASSAY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; PROGNOSIS; PROSPECTIVE STUDY; PROTEIN BLOOD LEVEL; PROTEIN DETERMINATION; RECEIVER OPERATING CHARACTERISTIC; RISK ASSESSMENT; SCORING SYSTEM; SEPSIS; SEPTIC SHOCK; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME;

ADRENOMEDULLIN; ADULT; C-REACTIVE PROTEIN; CALCITONIN; CRITICAL ILLNESS; FEMALE; HUMANS; INTENSIVE CARE UNITS; INTERLEUKIN-6; MALE; MIDDLE AGED; PEPTIDE FRAGMENTS; POSTOPERATIVE COMPLICATIONS; PROTEIN PRECURSORS; RISK ASSESSMENT; SEPSIS; SHOCK, SEPTIC; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME;

EID: 51349121483     PISSN: 10030603     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (17)

1. Eichacker PQ, Parent C, Kalil A, et al. Risk and the efficacy of antiinflammatory agents: retrospective and confirmatory studies of sepsis [J]. Am J Respir Crit Care Med, 2002, 166(9): 1197-1205.
2. Chinese source.
3. Christ-Crain M, Morgenthaler NG, Stolz D, et al. Pro-adrenomedullin to predict severity and outcome in community-acquired pneumonia[J]. Crit Care, 2006, 10(3):R96.
4. Gegenhuber A, Struck J, Dieplinger B, et al. Comparative evaluation of B-type natriuretic peptide, mid-regional pro-A-type natriuretic peptide, mid-regional pro-adrenomedullin, and Copeptin to predict 1-year mortality in patients with acute destabilized heart failure [J]. J Card Fail, 2007, 13 (1): 42-49.
5. Anon. American College of Chest Physicians/Society of Critical Care Medicine Consensus Conference: definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis[J]. Crit Care Med, 1992, 20(6):864-874.
6. Chinese source.
7. Levy MM, Fink MP, Marshall JC, et al. 2001 SCCM/ESICM/ACCP/ATS/SIS international sepsis definitions conference [J]. Crit Care Med, 2003, 31(4):1250-1256.
8. Lemaout C, Gonzalez H, Aboab J, et al. Pathophysiology of septic shock[J]. Presse Med, 2006, 35(3 Pt 2):521-527.
9. Dellinger RP, Carlet JM, Masur H, et al. Surviving sepsis campaign guidelines for management of severe sepsis and septic shock[J]. Crit Care Med, 2004, 32(3):858-873.
10. Chinese source.
11. Chinese source.
12. Castelli GP, Pognani C, Cita M, et al. Procalcitonin, C-reactive protein, white blood cells and SOFA score in ICU: diagnosis and monitoring of sepsis [J]. Minerva Anestesiol, 2006, 72 (1-2):69-80.
13. Elmas E, Lang S, Dempfle CE, et al. Diagnostic performance of mid-regional pro-adrenomedullin as an analyte for the exclusion of left ventricular dysfunction[J]. Int J Cardiol, 2008, 128 (1):107-111.
14. Christ-Crain M, Morgenthaler NG, Struck J, et al. Mid-regional pro-adrenomedullin as a prognostic marker in sepsis: an observational study[J]. Crit Care, 2005, 9(6):R816-824.
15. Chinese source.
16. Chinese source.
17. Chinese source.